Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-04-08
1994-02-01
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514866, A61K 31195
Patent
active
052832600
ABSTRACT:
A method for administering pyruvate is disclosed which comprises administering a therapeutically effective amount of a pyruvate precursor to a mammal in the form of pyruvamide or a pyruvyl-amino acid. The pyruvyl-amino acid is preferably selected from the group comprising pyruvyl-glycine, pyruvyl-alanine, pyruvyl-leucine, pyruvyl-valine, pyruvyl-isoleucine, pyruvylphenyl al anine, pyruvyl-proline and pyruvyl-sarcosine, and their amides and esters as well as their salts. Associated with the administration of a pyruvate precursor to a mammal in accordance with this invention are improved insulin resistance, lower fasting insulin levels, and reduced fat gain. Novel methods of synthesizing several pyruvate precursors are also disclosed.
REFERENCES:
patent: 3838027 (1974-09-01), Berntsson et al.
patent: 4197316 (1980-04-01), Yu et al.
patent: 4296127 (1981-10-01), Walser
patent: 4320145 (1982-03-01), Cavazza
patent: 4351835 (1982-09-01), Stanko
patent: 4548937 (1985-10-01), Stanko
patent: 4734276 (1988-03-01), ziegler
patent: 4874790 (1989-10-01), Stanko
patent: 5053527 (1991-10-01), Christidis et al.
patent: 5089492 (1992-02-01), Gerling et al.
"Transamination of Peptides", Dixon, Biochemistry Journal, vol. 92, pp. 661-666, (1964).
"Prevention of Alcohol-Induced Fatty Liver By Natural Metabolite and Riboflavin", Stanko et al, Journal of Laboratory and Clinical Medicine, Feb. 1978.
"Inhibition of Lipid Accumulation and Enhancement of Energy Expenditure by the Addition of Pyruvate and Dihydroxyacetone to a Rat Diet", Stanko et al. Metabolism, vol. 35, No. 2, Feb. 1986, pp. 182-186.
Remington's Pharmaceutical Sciences 16th Edition (1980) p. 431.
Pellegata et al. Synthesis, May 1985, pp. 517-519.
Cipollo Kent L.
Dhaon Madhup K.
Houbion John A.
Lundell Edwin O.
Miller Robert H.
Abbott Laboratories
Drayer Lonnie R.
Henley III Raymond J.
Nickey Donald O.
Waddell Frederick E.
LandOfFree
Method for reducing insulin resistance in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing insulin resistance in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing insulin resistance in mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-580079